Peptidomimetic Peptides

Peptidomimetic peptides are synthetic molecules designed to mimic natural peptides, enhancing stability and bioavailability for therapeutic use. Unlike traditional peptides, they resist enzymatic degradation, improving pharmacokinetics and efficacy in treating diseases like cancer, infections, and neurological disorders. Key benefits include targeted receptor binding, reduced side effects, and versatile modifications for next-gen drugs. In 2026, applications span antiviral agents, anti-aging therapies, and muscle recovery supplements.